9.58
+0.81(+9.24%)
Currency In USD
| Previous Close | 8.77 |
| Open | 9.13 |
| Day High | 9.59 |
| Day Low | 8.5 |
| 52-Week High | 11.72 |
| 52-Week Low | 1.45 |
| Volume | 4.08M |
| Average Volume | 781,103 |
| Market Cap | 318.03M |
| PE | -2.98 |
| EPS | -3.21 |
| Moving Average 50 Days | 5.9 |
| Moving Average 200 Days | 4.44 |
| Change | 0.81 |
If you invested $1000 in Lexeo Therapeutics, Inc. Common Stock (LXEO) since IPO date, it would be worth $953.23 as of October 20, 2025 at a share price of $9.58. Whereas If you bought $1000 worth of Lexeo Therapeutics, Inc. Common Stock (LXEO) shares 1 year ago, it would be worth $910.65 as of October 20, 2025 at a share price of $9.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
GlobeNewswire Inc.
Oct 17, 2025 3:29 AM GMT
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has priced its underwritten
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Oct 16, 2025 8:32 PM GMT
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
GlobeNewswire Inc.
Oct 07, 2025 10:00 AM GMT
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data show sustained or deepening impro